Par Drugs and Chemicals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)
Par Drugs and Chemicals Ltd · Outcome · 29 Oct 2026, 10:31 pm
Par Drugs and Chemicals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 2,743 (-4.3% YoY | -12.3% QoQ) ■ EBITDA: 450 (-25.8% YoY | -29.4% QoQ) ■ EBITDA Margin (%): 16.4 (-475 bps YoY | -398 bps QoQ) ■ PAT: 263 (-36.4% YoY | -44.2% QoQ) ■ EPS (INR): 2.14 (-36.3% YoY | -44.1% QoQ)
Original exchange filing (PDF)
More announcements from Par Drugs and Chemicals Ltd
- Par Drugs And Chemicals Limited has informed the Exchange regarding 'Outcome of Board Meeting dated 29.10.2026'. · 29 Oct 2026
- Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on October 29, 2026. · 29 Oct 2026
- PAR DRUGS AND CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 29 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters · 29 Oct 2026
- Par Drugs And Chemicals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 26, 2026. Further, the company has informed the Exchange regarding voting results. · 27 Sept 2026
- Par Drugs And Chemicals Limited has informed the Exchange regarding 'Proceeding of AGM dated 26.09.2026'. · 26 Sept 2026
- Par Drugs And Chemicals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 26, 2026 · 26 Sept 2026
- Par Drugs And Chemicals Limited has informed the Exchange regarding 'Regulation 36 (1)(b)'. · 01 Sept 2026
